Skip to main content
logo
AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.760
+0.070 (2.60%)
Sep 11, 2026, 4:00 PM EDT - Market closed

AC Immune Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17.513.5727.3114.83.94-
Revenue Growth
-39.45%-86.92%84.51%276.14%--
Gross Profit
-28.41-52.86-35.26-39.81-56.4-62.28
Operating Income
-43.7-68.86-52.38-53.62-70.85-79.01
Net Income
-43.16-70.45-50.92-54.23-70.75-73
Earnings Per Share
-0.43-0.70-0.51-0.64-0.85-0.97
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
75.3691.41165.49103.05122.59198.22
Total Debt
4.14.545.433.52.82.91
Net Cash (Debt)
71.2686.87160.0699.55119.79195.31
Net Cash Growth
-41.70%-45.73%60.78%-16.89%-38.67%-12.68%
Net Cash Per Share
0.700.861.611.181.432.61

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-50.49-69.2665.84-60.41-73.57-65.69
Capital Expenditures
-0.59-0.9-0.58-0.8-1.24-2.64
Free Cash Flow
-51.09-70.1665.27-61.21-74.81-68.32
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-162.23%--129.12%-268.94%--
Operating Margin
-249.58%-1927.32%-191.80%-362.30%-1800.43%-
Pretax Margin
-246.48%-1971.65%-186.43%-366.35%-1797.71%-
Profit Margin
-246.48%-1971.65%-186.44%-366.41%-1798.04%-
FCF Margin
-291.78%-1963.67%238.99%-413.55%-1901.07%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
45.4914.2114.2166.3866.3866.38
P/FCF Ratio
--3.71---
PS Ratio
12.6668.958.8628.1137.03-